BIT 2.63% 3.7¢ biotron limited

News flow potential short to mid term (2022) share price...

  1. 5,303 Posts.
    lightbulb Created with Sketch. 652
    News flow potential short to mid term (2022) share price catalyst. Not in order.

    FDA Fast Track to phase 2 human trials CTAP.
    Non Equity funding arrangement. (Likely Trading Halt)
    Small Trial 1 (5 day course BIT225) outside US in Large Covid Population.
    Large FDA trial in US possible 30 cohort (8kg BIT225)
    FDA approval 9-12months
    Buyout possible anytime.

    HIV current studies Immune response combined with ART mid 2022.

    Current SP 9c
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
-0.001(2.63%)
Mkt cap ! $33.38M
Open High Low Value Volume
3.9¢ 4.0¢ 3.7¢ $38.58K 1.029M

Buyers (Bids)

No. Vol. Price($)
2 511933 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 93887 2
View Market Depth
Last trade - 14.30pm 03/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.